10 employees
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.
2019
$2M
from 4 investors over 4 rounds
Exogene Ltd. raised $2M on April 25, 2022
Investors: Selvedge Venture, R42 Group, Unruly Capital and Knowledge Quarter